CD276-targeted chimeric antigen receptor T cells

CD276-targeted CAR-T cells · Shenzhen University General Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD276-targeted chimeric antigen receptor T cells, covering 2021-12-03 to 2021-12-03. Get the full timeline:

Most recent: Clinical Trial Update: CD276-targeted Chimeric Antigen Receptor T Cells in Treatment With Advanced Pancreatic Cancer [Phase 1, Phase 2]